(VENCLEXTA (Venetoclax) 100mg/120tablets is registered trademarks ABBVIE INC)
General Warning: The tumor lysis syndrome risk is very high in the case of conception of this medicine medicated with anti-hyperuricemic and adequate hydration is necessary.
Generic Name: Venetoclax
Strength: 50 mg, 100 mg
Company: ABBVIE INC
Packing: 100 tablets in one bottle
What is VENCLEXTA:
VENCLEXTA (Venetoclax) 100mg/120tablets is a medicine that contains the active substance Venetoclax and is available as Tablets. https://jonabiotech.com/
Venclexta – Venetoclax 50 mg, 100 mg is supplied for Tenders, Emergency imports, Orphan drug, Reference listed drugs, Comparator Drug, Name patient medicine and Innovator samples etc.
Venetoclax is available as Venclyxto in Europe.
Venetoclax Uses: Venetoclax belongs to a BCL-2 inhibitor class drug used for the treatment of chronic lymphocytic anemia in adult patients or small lymphocytic lymphoma. This drug is used in a patient who has at least one prior therapy.
Venetoclax, sold under the brand names Venclexta and Venclyxto, is a medication used to treat adults with chronic lymphocytic leukemia or small lymphocytic lymphoma. The most common side effects are low levels of neutrophils, diarrhea, nausea, anemia, nose and throat infection and tiredness.
Other names: GDC-0199, ABT-199, RG-7601
Elimination half-life: ~26 hours
Molar mass: 868.45 g·mol−1
ATC code: L01XX52 (WHO)
License data: EU EMA: by INN; US DailyMed: Venetoclax
Metabolism: Liver (CYP3A4, CYP3A5)